Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Association between circulating adipocytokine concentrations and microvascular complications in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of controlled cross-sectional studies

Loading...
Thumbnail Image

Date

Authors

Rodriguez, Alexander
dos Santos Nunes, Vania
Mastronardi, Claudio
Neeman, Teresa
Da Paz Filho, Gilberto

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

Background: The adipocytokines leptin and adiponectin have been variously associated with diabetic microvascular complications. No comprehensive clinical data exist examining the association between adipocytokines and the presence of these complications. Methods: This is a systematic review of cross-sectional studies comparing circulating adipocytokines in patients with type 2 diabetes mellitus (T2DM), with and without microvascular complications. Studies were retrieved from MEDLINE, EMBASE, Scopus and Cochrane databases. Study quality was evaluated using a modified Newcastle– Ottawa Scale. Meta-analysis was performed using an inverse-variance model, providing standardised mean differences (SMD) and 95% confidence intervals (CI). Heterogeneity was determined by I2 statistic. Results: Amongst 554 identified studies, 28 were included in the review. Study quality range was 3.5–9 (maximum 11). Higher leptin levels were associated with microalbuminuria (SMD = 0.41; 95% CI = 0.14–0.67; n = 901; p = 0.0003), macroalbuminuria (SMD = 0.68; 95% CI = 0.30–1.06; n = 406; p = 0.0004), and neuropathy (SMD = 0.26; 95% CI = 0.07–0.44; n = 609; p = 0.008). Higher adiponectin levels were associated with microalbuminuria (SMD = 0.55; 95% CI = 0.29–0.81, n = 274; p b 0.001), macroalbuminuria (SMD = 1.37; 95% CI = 0.78–1.97, n = 246; p b 0.00001), neuropathy (SMD = 0.25; 95% CI = 0.14–0.36; n = 1516; p b 0.00001), and retinopathy (SMD = 0.38; 95% CI = 0.25–0.51; n = 1306; p b 0.00001). Meta-regression suggested no influence of body mass index and duration of diabetes on effect size, and a weak trend in terms of age on effect size. Discussion: Our meta-analysis suggests leptin and adiponectin levels are higher in T2DM patients with microvascular complications. Studies were limited by cross-sectional design. Large prospective analyses are required to validate these findings.

Description

Keywords

Citation

Source

Journal of Diabetes and its Complications

Book Title

Entity type

Access Statement

License Rights

Restricted until

2037-12-31